Drug for treating rheumatoid arthritis

Abstract

The invention relates to a drug for treating rheumatoid arthritis. The drug for treating the rheumatoid arthritis is prepared from, by weight, 2 parts of Chinese pyrola herbs, 3 parts of radix paeoniae alba, 3 parts of phlomis medicinalis diels, 4 parts of herba lycopodii, 3 parts of ramulus mori, 5 parts of rhizoma et radix notopterygii, 3 parts of radix saposhnikoviae and 6 parts of Chinese wolfberry fruit. According to the drug for treating the rheumatoid arthritis, Chinese pyrola herbs have the functions of clearing damp and strengthening tendons; radix paeoniae alba has the functions of calming the liver, relieving pains and nourishing blood for regulating menstruation; phlomis medicinalis diels has the functions of expelling wind-damp and expelling wind-damp; herba lycopodii has the functions of dispelling wind, eliminating dampness, relaxing tendons and activating collaterals; ramulus mori has the functions of expelling the wind-damp and facilitating joints; rhizoma et radix notopterygii has the functions of dispelling cold and wind-evil, removing damp and stopping the pains; radix saposhnikoviae has the functions of relieving exterior syndrome and dispelling the wind-evil; Chinese wolfberry fruit has the function of nourishing the liver and the kidney. All the medicines are combined for use, the efficacy of tonifying the kidney, dredging collaterals, dispelling the wind and eliminating the damp is achieved through all the medicines, and the rheumatoid arthritis is effectively treated. According to clinical experiments, it is verified that the drug can safely and effectively treat the rheumatoid arthritis.

Description

technical field [0001] The invention relates to a traditional Chinese medicine, in particular to a medicine for treating rheumatoid arthritis. Background technique [0002] Rheumatoid arthritis is an inflammatory autoimmune disease mainly involving the surrounding joints. Characteristic Linchuan manifests as symmetrical, peripheral, chronic inflammatory lesions in multiple joints. May be accompanied by extra-articular systemic damage. The basic pathological change is chronic synovitis leading to destruction of articular cartilage and bone. The age of onset is mostly 30-50 years old, and the male to female ratio is 1:3. [0003] Clinical manifestations: ① Joint manifestations Joint involvement is often symmetrical. The specific manifestations are pain and tenderness: mostly persistent dull pain or distending pain; swelling; morning stiffness: lasting more than 1 hour; deformity: ulnar deviation and swan neck deformity; dysfunction. ② external joint performance of rheumat...

AI Technical Summary

Problems solved by technology

However, in addition to common side effects such as nausea and vomiting, western medicine also has serious adverse reactions such as hair loss, pneumonia, and kidney damage.